We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+16.29%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.82B
AUM Growth
+$1.31B
Cap. Flow
+$158M
Cap. Flow %
2.03%
Top 10 Hldgs %
19.27%
Holding
869
New
65
Increased
350
Reduced
240
Closed
81

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$43.7M
2
BMY icon
Bristol-Myers Squibb
BMY
+$30.4M
3
GILD icon
Gilead Sciences
GILD
+$28.3M
4
BIIB icon
Biogen
BIIB
+$26.7M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$25.2M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$75.2M
2
LOXO
Loxo Oncology, Inc
LOXO
+$28.1M
3
DHR icon
Danaher
DHR
+$27.9M
4
A icon
Agilent Technologies
A
+$26.4M
5
MKC icon
McCormick & Company Non-Voting
MKC
+$18M

Sector Composition

Rank Sector Weight
1 Healthcare 33.36%
2 Technology 15.96%
3 Financials 11.25%
4 Consumer Discretionary 8.98%
5 Communication Services 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HLT icon
426
Hilton Worldwide
HLT
$72.9B
$2.77M 0.04%
19,378
-12
-0.1% -$939
HIFR
427
DELISTED
InfraREIT, Inc.
HIFR
$2.77M 0.04%
131,885
+30,885
+31% +$654K
NEO icon
428
NeoGenomics
NEO
$1.73B
$2.73M 0.03%
+133,201
New +$2.31M
PKG icon
429
Packaging Corp of America
PKG
$22.8B
$2.73M 0.03%
27,415
-21,192
-44% -$2.01M
NUE icon
430
Nucor
NUE
$59.6B
$2.71M 0.03%
46,495
-2,715
-6% -$159K
KHC icon
431
Kraft Heinz
KHC
$32.5B
$2.71M 0.03%
82,897
+15,384
+23% +$627K
AIG icon
432
American International
AIG
$42.7B
$2.67M 0.03%
61,986
– –
GWW icon
433
W.W. Grainger
GWW
$66.4B
$2.66M 0.03%
8,844
-1,028
-10% -$306K
FISV
434
Fiserv Inc
FISV
$28.5B
$2.66M 0.03%
30,122
-906
-3% -$74.8K
PPG icon
435
PPG Industries
PPG
$27.1B
$2.65M 0.03%
23,520
+342
+1% +$36.6K
ADM icon
436
Archer Daniels Midland
ADM
$40.5B
$2.64M 0.03%
61,186
+4,613
+8% +$197K
DINO icon
437
HF Sinclair
DINO
$16.2B
$2.64M 0.03%
53,500
-1,728
-3% -$92K
NTRS icon
438
Northern Trust
NTRS
$22.2B
$2.61M 0.03%
28,901
-275
-0.9% -$24.8K
GAP
439
The Gap Inc
GAP
$7.28B
$2.54M 0.03%
97,131
-205,764
-68% -$5.26M
DISH
440
DELISTED
DISH Network Corp.
DISH
$2.52M 0.03%
79,634
-1,912
-2% -$58.6K
LJPC
441
DELISTED
La Jolla Pharmaceutical Company
LJPC
$2.52M 0.03%
392,300
– –
HMC icon
442
Honda
HMC
$39.1B
$2.5M 0.03%
92
– –
TROW icon
443
T. Rowe Price
TROW
$25.9B
$2.49M 0.03%
24,903
+3,186
+15% +$307K
NITE
444
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
$2.46M 0.03%
+97,043
New +$1.72M
STZ icon
445
Constellation Brands
STZ
$22.9B
$2.46M 0.03%
14,018
+770
+6% +$130K
AKBA icon
446
Akebia Therapeutics
AKBA
$335M
$2.46M 0.03%
300,000
– –
AME icon
447
Ametek
AME
$55.7B
$2.44M 0.03%
29,439
-5,166
-15% -$393K
SNA icon
448
Snap-on
SNA
$21.6B
$2.43M 0.03%
15,506
-920
-6% -$146K
HBAN icon
449
Huntington Bancshares
HBAN
$35B
$2.41M 0.03%
190,164
-19,810
-9% -$266K
O icon
450
Realty Income
O
$61.8B
$2.41M 0.03%
33,812
+8,524
+34% +$565K
16 17
18
19 20

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2019 Portfolio in Review

As of Q1 2019, Candriam SCA held 869 positions worth $7.82B, up 20% from $6.51B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Candriam SCA's Q1 2019 filing shows 65 new, 350 increased, 240 reduced and 81 closed positions. Its largest new stake was Baozun: 640,000 shares worth $26.6M. The largest sale was Celgene Corp, an estimated $75.2M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 35% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q1 2019 buy was Baozun: 640,000 shares worth $26.6M.
  • Candriam SCA added most to Merck in Q1 2019, an estimated $43.7M increase.
  • Candriam SCA's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $75.2M.
  • Candriam SCA fully exited Loxo Oncology, Inc in Q1 2019, selling an estimated $28.1M.
  • Candriam SCA's ten largest holdings make up 19% of its $7.82B portfolio in Q1 2019.
  • Candriam SCA opened 65 new positions and closed 81 in Q1 2019.
  • Candriam SCA's portfolio value rose 20% quarter-over-quarter to $7.82B.

Based on Candriam SCA's 13F filing for Q1 2019, filed 2 May 2019.